OKYO Pharma OKYO
NASDAQ OKYO
$1.62 +0.25 (+18.25%)
As of: Oct 21, 2026 · 2:00 PM EDT

OKYO Pharma (OKYO) Receivables - Net (2021 - 2026)

Updated

OKYO Pharma (OKYO) recorded Receivables - Net of $375,749 in the quarter ended Mar 31, 2026, up 55.0% from $242,342 a year earlier.

Analysis

OKYO Pharma (OKYO) Receivables - Net (2021 - 2026) Analysis & Trends

Starting with the quarter ended Mar 31, 2021, OKYO Pharma's Receivables - Net history includes 6 quarters.

  • Annual Receivables - Net has a five-year compound annual growth rate of 54.0% (years ended Mar 2021 to Mar 2026).
  • Across earlier years, Receivables - Net came in at $242,342 in the year ended Mar 31, 2025 (+59.5%), $151,938 in the year ended Mar 31, 2024 (-74.3%), $592,195 in the year ended Mar 31, 2023 (-27.2%) and $812,956 in the year ended Mar 31, 2022.
  • The figure for the quarter ended Mar 31, 2026 is the highest quarterly Receivables - Net since the quarter ended Mar 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.19 Bn 1,101.77 Bn 19.71 Bn
2 Johnson & Johnson 616.03 Bn 534.56 Bn 17.26 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 366.82 Bn 321.20 Bn 12.21 Bn
5 Novartis Ag 297.82 Bn 261.81 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 235.89 Bn 191.29 Bn 7.24 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn
9 Pfizer 169.32 Bn 115.96 Bn 10.94 Bn
10 OKYO Pharma 1.09 Bn 1.06 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 375,749.00
Mar 31, 2025 242,342.00
Mar 31, 2024 151,938.00
Mar 31, 2023 592,195.00
Mar 31, 2022 812,956.00
Mar 31, 2021 43,370.00
API Access

OKYO Pharma Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=OKYO&period=max&api_key=YOUR_API_KEY